For laboratory research use only. Not for human or veterinary use. Sold to qualified researchers 21+. Research-use terms

Free standard shipping on orders $175+ Shop →

Peptide chemistry

What impurities are found in synthetic peptides, and how does a COA show them?

By · Published · updated · vendor-authored explanatory note

Short answer

Most synthetic peptides are made by Fmoc solid-phase peptide synthesis (SPPS), and its typical by-products are deletion and insertion sequences, truncated chains, racemized residues, leftover protecting-group adducts, aspartimide products, oxidized residues and dimers. A finished powder also contains non-peptide material: counter-ions such as trifluoroacetate, water and traces of solvent. HPLC purity measures only the first group, by UV peak area, so LC-MS identity and a quantity or net peptide content result are needed to see the rest.

Catalog materials discussed on this page

Common impurity types in Fmoc SPPS peptides, where they come from, and which result shows them.
ImpurityUsual originMass shift vs targetSeen by
Deletion sequenceIncomplete coupling or Fmoc removal in one cycleMinus one residue massLC-MS; often a peak beside the main HPLC peak
Insertion sequenceExcess activated amino acid adds a residue twicePlus one residue massLC-MS; HPLC
Truncated sequenceChain growth stopped (for example after capping)Shorter fragmentHPLC; LC-MS
Diastereomer (racemized residue)Base or activation conditions flip one residue's chiralityNone (same mass)HPLC only, if the method separates it
Protecting-group adductSide-chain protection not fully removed at cleavagePlus the group (for example +56 Da for tert-butyl)LC-MS
Aspartimide and isomersBase-catalysed ring closure at aspartic acid-18 Da, then same-mass alpha/beta isomersLC-MS plus HPLC
OxidationMethionine or tryptophan oxidized by air or reagents+16 Da per oxygenLC-MS
Dimer or oligomerDisulfide scrambling or aggregationAbout twice the massLC-MS; size-exclusion methods
Counter-ion (TFA or acetate)Cleavage and reverse-phase purificationNot part of the peptideIon chromatography or 19F NMR; net peptide content
Water and residual solventHygroscopic powder; synthesis and purification solventsNot part of the peptideKarl Fischer; headspace GC; not HPLC purity

Where synthetic peptide impurities come from

In Fmoc SPPS, the peptide is built one amino acid at a time on a resin bead. Each cycle removes the Fmoc group from the growing chain and couples the next protected amino acid. At the end, a strong acid (usually trifluoroacetic acid) cuts the peptide off the resin and strips the side-chain protecting groups, and the crude product is purified by reverse-phase HPLC and freeze-dried.

Every one of those steps runs at less than 100 percent. A long sequence goes through dozens of cycles, so even a small per-cycle loss leaves a population of closely related chains. A 2014 review of peptide-related impurities groups them into synthesis-related impurities and degradation products, and notes that both can change the outcome of early functionality studies. That is the practical reason a research lab cares about them.

Deletion sequences, missing one residue, come from a coupling or Fmoc removal that did not go to completion. Insertion sequences, with one residue added twice, come from excess activated amino acid. Both differ from the target by exactly one residue mass, which makes them easy to spot by LC-MS and hard to remove by HPLC because they behave so much like the target.

Racemization changes one residue from its L form to its D form. The result, a diastereomer, has the same mass as the target, so mass spectrometry alone cannot see it; only a chromatographic method that separates the two can. Incomplete side-chain deprotection leaves adducts such as a tert-butyl group still attached (+56 Da).

Aspartimide formation is a well-known side reaction at aspartic acid residues, especially in Asp-Gly sequences. The ring-closed aspartimide is 18 Da lighter than the target, and when it reopens it gives alpha- and beta-aspartyl peptides of the same mass as the target. A 2025 review in ChemBioChem summarizes the protecting-group strategies developed to suppress it.

Oxidation of methionine (+16 Da) and tryptophan can happen during synthesis, cleavage or later storage. Degradation that happens after manufacture, such as deamidation or pyroglutamate formation, is covered in our guide to peptide degradation pathways.

Non-peptide content: counter-ions, water and solvents

A lyophilized peptide is never 100 percent peptide by weight. Basic residues carry counter-ions from cleavage and purification, most often trifluoroacetate unless the material was exchanged to acetate or another salt. Our TFA vs acetate guide covers why the salt form changes the weight of peptide in a vial.

Freeze-dried peptides also hold water, because the powder is hygroscopic, and can retain traces of the solvents used in synthesis and purification. ICH Q3C, published by FDA, classifies common solvents by hazard: acetonitrile, N,N-dimethylformamide and dichloromethane are Class 2 solvents, and diethyl ether and tert-butyl methyl ether are Class 3. Water is measured by Karl Fischer titration and solvents by headspace gas chromatography; neither appears in an HPLC purity figure.

What an HPLC purity number does and does not cover

HPLC purity is the main peak's share of the total UV peak area, usually at 214 to 220 nm where the peptide bond absorbs. It ranks the peptide-related impurities that the column separates. It does not count water, salts or solvents, and an impurity that co-elutes under the main peak is counted as product.

That is why two certificates with similar purity figures can describe very different vials. Net peptide content, or a measured quantity in milligrams, is the result that accounts for the non-peptide mass. The validation of the method itself, its specificity, accuracy and precision, is described in ICH Q2(R2).

How to read a COA for impurity information

Five checks that use only what is printed on the certificate.

  1. Find the identity result: an LC-MS observed mass that agrees with the mass calculated from the sequence rules out most wrong-sequence and missing-residue problems in the main peak.
  2. Look at the chromatogram, not just the number: small peaks close to the main peak are often deletion, insertion or isomer impurities; a report with no chromatogram cannot be checked.
  3. Note the detection wavelength and method: HPLC purity is a UV area ratio, so it reflects only peptide-like material that absorbs at that wavelength and separates on that column.
  4. Look for a counter-ion or salt form: trifluoroacetate or acetate content is part of the powder weight but is invisible to HPLC purity.
  5. Look for quantity or net peptide content: this is the result that accounts for water, counter-ions and other non-peptide mass.

Scope of this guide

This page describes analytical chemistry for in-vitro laboratory research use only. It makes no claim about the purity of any particular lot; a published lot report, where one exists, is the only source for that. Vitality Chems publishes its lot reports on the testing page and in the COA dataset.

Frequently asked

What are the most common impurities in synthetic peptides?

Deletion and insertion sequences, truncated chains, racemized residues, protecting-group adducts, aspartimide products, oxidized residues and dimers, plus non-peptide content such as counter-ions, water and residual solvents.

What is a deletion sequence in peptide synthesis?

A chain missing one amino acid because a coupling or Fmoc removal step did not finish. It is lighter than the target by one residue mass, so LC-MS shows it clearly.

Does HPLC purity include TFA and water?

No. HPLC purity is a UV peak-area ratio among peptide-like material. Counter-ions, water and solvents are measured by other methods and show up in net peptide content.

Can mass spectrometry detect every peptide impurity?

No. Racemized residues and alpha/beta aspartyl isomers have the same mass as the target, so only a chromatographic method that separates them can show them.

What is aspartimide formation?

A base-catalysed side reaction at aspartic acid during Fmoc SPPS. It forms a ring that is 18 Da lighter than the target and can reopen into same-mass isomers.

References

  1. D'Hondt M, et al. Related impurities in peptide medicines. J Pharm Biomed Anal. 2014;101:2-30. PMID 25044089Review of SPPS-related and degradation impurities: deletion, insertion, racemization, protection adducts, oxidation, counter-ions.
  2. Behrendt R, White P, Offer J. Advances in Fmoc solid-phase peptide synthesis. J Pept Sci. 2016;22(1):4-27. PMID 26785684Fmoc SPPS chemistry and its side reactions.
  3. Kong MJW, van den Braak TJHP, Neumann K. Aspartimide formation and its prevention in Fmoc chemistry solid phase peptide synthesis. ChemBioChem. 2025;26(18):e202500490. PMID 40857621Mechanism and suppression strategies for aspartimide formation.
  4. FDA: Q3C Tables and List Rev. 4 (ICH residual solvents)Solvent classes (acetonitrile, DMF and dichloromethane Class 2; diethyl ether and tert-butyl methyl ether Class 3).
  5. FDA: Q2(R2) Validation of Analytical Procedures (final guidance, March 2024)Validation characteristics for analytical methods.